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Diabetes rates are on the rise, particularly among members of racial and ethnic 
minority groups. Individuals with diabetes are more vulnerable to developing depressive 
symptoms when compared to those without diabetes. While there appear to be no racial 
and ethnic differences in depression prevalence estimates among individuals with 
diabetes, members of racial and ethnic minority groups are less likely to achieve 
glycemic control over time, and may be at greater risk for diabetes related health issues.  
One such health issue is sexual dysfunction, with individuals with diabetes being 
more vulnerable to sexual dysfunction than those without diabetes. Sexual dysfunction 
may have significant biopsychosocial impacts on an individual’s ability to manage their 
diabetes. However, the potential impact of sexual dysfunction on glycemic control is still 
unclear. Possible racial and ethnic differences in the prevalence of sexual dysfunction 
among individuals with diabetes are unknown. The relationship between, and potential 
long-term impact of, depression and sexual dysfunction on glycemic control has received 
very little attention in the diabetes research literature. This study sought to address this 
gap in the literature, as well as contribute more information regarding possible racial and 
ethnic differences in outcomes among individuals with diabetes by examining racial 
differences in glycemic control, the prevalence of depression and sexual dysfunction, and 
the longitudinal impact of these disorders on glycemic control among a national sample 
of veterans. Racial and ethnic differences in prevalence of depression and sexual 




race and depression/sexual dysfunction status on glycemic control over time were 
expected. 
Data from 50,039 veterans with diabetes were included in the current 
investigation. Relevant data were extracted from the Veteran’s Affairs (VA) Informatics 
and Computing Infrastructure (VINCI), which is partnered with the Corporate Data 
Warehouse (CDW) that manages VA patient health records. Veterans were classified as 
depressed or experiencing sexual dysfunction based on ICD-9 codes for depression and 
sexual dysfunction. General linear mixed model regression analyses were conducted 
examine changes over time, represented by age, in A1C levels among the different 
diagnostic groups. Post-hoc curvilinear analyses of longitudinal models were also 
conducted.   
The findings revealed racial and ethnic differences in the prevalence of depression 
and sexual dysfunction among veterans with diabetes, with White American veterans 
having higher percentage rates of depression (phi = .02) and Black American veterans 
having higher percentage rates of sexual dysfunction (phi = .12). Findings for both linear 
and curvilinear analyses of longitudinal models also revealed significant differences in 
A1C levels across racial and ethnic groups, as well as diagnostic groups, over time. 
Specifically, Black American veterans and veterans with sexual dysfunction exhibited 
decreasing mean A1C levels over time while White American veterans and veterans with 
no diagnosis exhibited gradually increasing mean A1C levels over time. Significant racial 
and ethnic differences in A1C levels were also present among veterans with depression. 
Findings suggest possible impact of race, sexual dysfunction, and depression on long-
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Due to continually rising prevalence rates of diabetes in the last decade, there has 
been a strong and persistent increase in diabetes research. The Centers for Disease 
Control (CDC) estimates that diabetes affects nearly 26 million people in the United 
States, meaning that about eight percent of the U.S. population has diabetes (CDC, 2011). 
The majority of persons with diabetes have either type 1 or type 2 diabetes, although 
other types of diabetes are recognized (e.g., gestational diabetes or diabetes resulting 
from a specific genetic or medical condition) (CDC, 2011).  
Type 1 diabetes accounts for 5% to 10% of all diagnosed cases of diabetes in 
adults, and develops when the body's immune system destroys pancreatic beta cells 
(CDC, 2011). Since these are the only cells in the body that make insulin, people with 
type 1 diabetes must have insulin delivered by injection or a pump in order to survive 
(CDC, 2011).  Type 2 diabetes is more common than type 1 diabetes, accounting for 
about 90% to 95% of all diagnosed cases in adults. It usually begins as insulin resistance, 
a disorder in which the cells do not use insulin properly; as the need for insulin rises, the 
pancreas gradually loses its ability to produce the hormone. Type 2 diabetes is associated 
with a number of risk factors, including older age, obesity, family history of diabetes, 





Members of racial and ethnic minority groups are at high risk for diabetes. After 
adjusting for population age differences, a 2007–2009 national survey of persons aged 20 
years or older indicated that 7.1% of non-Hispanic Whites, 8.4% of Asian Americans, 
11.8% of Hispanics, and 12.6% of non-Hispanic Blacks had been diagnosed diabetes. 
Among all non-White Hispanics surveyed, rates were 7.6% for both Cubans and for 
Central and South Americans, 13.3% for Mexican Americans, and 13.8% for Puerto 
Ricans (CDC, 2011). Members of racial and ethnic minority groups, particularly Black 
Americans, are also at greater risk for experiencing medical complications due to 
diabetes when compared to White Americans (CDC, 2011).  
Such prevalence rates are problematic due to their associated health risks. Adults 
with diabetes have heart disease death rates about 2 to 4 times higher than adults without 
diabetes, and the risk for stroke is 2 to 4 times higher among people with diabetes (CDC, 
2011). Also, diabetes is the leading cause of new cases of blindness among adults and is 
the leading cause of kidney failure, accounting for 44% of new cases in 2008 (CDC, 
2011). Furthermore, about 60% to 70% of all persons diagnosed with diabetes have mild 
to severe forms of nervous system damage, as severe forms of diabetic nerve disease is a 
major contributing cause of lower-extremity amputations (CDC, 2011). Given these data, 
and as prevalence rates continue to rise, diabetes is clearly a serious medical condition 
that continues to significantly impact the American people. 
Diabetes and Depression 
While diabetes increases the risk of many physical health conditions, research 
suggests that patients with diabetes may also be at risk for co-morbid mental health 




indicated that the odds of depression among diabetics was twice that of the non-diabetic 
comparison group, a finding that was not contingent upon gender, type of diabetes, 
subject source, or assessment method (Anderson, Freeland, Clouse, & Lustman, 2001). 
The results of a more recent meta-analysis of ten controlled studies also suggested that 
the prevalence of depression was significantly higher in patients with type 2 diabetes 
compared with those without, with the prevalence of depression being higher among 
females with type 2 diabetes compared to males with diabetes (Ali, Stone, Peters, Davies, 
& Khunti, 2006).  Fisher, Skaff, Mullan, Arean, Glasgow, and Masharani (2008) 
explored the prevalence of affective disorders, depressive affect, and diabetes- specific 
emotional distress (i.e., negative emotions towards diabetes and its treatment) over time 
among 506 patients with type 2 diabetes. They found that patients with type 2 diabetes 
displayed high rates of affective disorders over an 18-month period, relative to 
community adults.  Specifically, patients with diabetes had 60% higher rates for major 
depressive disorder and 7% higher rates for dysthymia (persistent depressive episodes 
lasting longer than two years) compared to community adults without diabetes, with 
women and younger patients being at high risk for both conditions over time (Fisher et 
al., 2008).  
deGroot, Pinkerman, Wagner, & Hockman (2006) found no differences in 
depression scores between racial and ethnic groups or diabetes type, but results also 
suggested that Black Americans were less likely to report any depression treatment, 
receipt of antidepressant medications, or receipt of treatment from a mental health 
professional compared to White Americans. Wagner, Tsimikas, Heapy, de Groot, and 




symptoms were similar among White American, Black American, and non-White 
Hispanic patients with diabetes. However, Black Americans reported lower rates of 
physician-diagnosed depression than White Americans, and those Black Americans who 
endorsed depressive symptoms reported marginally lower rates of pharmacotherapy than 
White Americans.  
Overall, the results of these studies indicate that the prevalence of depression 
appears to be higher among patients with diabetes when compared to the general 
population. While there do not appear to be racial and ethnic differences in depression 
scores among diabetes patients, depression may often go undiagnosed in Black American 
diabetes patients. Black Americans are also less likely to receive treatment for depression 
when compared to White Americans. These issues may be related to racial and ethnic 
differences in the presentation of depressive symptoms, with Black Americans endorsing 
more somatic symptoms than affective symptoms or changes in mood when compared to 
White Americans (Baker, Okwumabua, Philipose, & Wong, 1996; Brown, Schulberg, & 
Madonia, 1996; Das, Olfson, McCurtis, & Weissman, 2006). This presentation may lead 
to providers to assume that there is only a physical health issue that needs to be treated 
and not a psychological issue. There are also racial and ethnic differences in attitudes 
about treatment for depression. A recent study of older Americans (individuals over age 
60) revealed that depressed older adults endorsed a high level of public stigma about 
mental health treatment, and were not likely to be currently engaged in or seek mental 
health treatment for their depression (Conner, Copeland, Grote, Koeske, Rosen, et al. 
2010). The also found that Black American older adults were more likely to internalize 




their White American counterparts. Such findings highlight the importance of 
understanding the impact of depression within a diabetes population, possibly paying 
particular attention to Black Americans to ensure accurate diagnosis and treatment of 
their depression. 
Impact of Diabetes and Depression on Physical Health 
Given the high prevalence of depression among patients with type 1 and type 2 
diabetes, there has been a growing interest in how depression impacts diabetes-related 
health complications and medical outcomes. The results of one meta-analytic 
investigation revealed a significant association between depression and a variety of 
diabetes complications among patients with type 1 and type 2 diabetes, including diabetic 
retinopathy, nephropathy, neuropathy, macrovascular complications, and sexual 
dysfunction (de Groot, Anderson, Freedland, Clouse, & Lustman, 2001). Other study 
results indicate that individuals with diabetes and depression report a poorer quality of 
life, including both physical and mental health difficulties, more frequently than those 
without depression (Ciechanowski, Katon, & Russo, 2000; Kaholokula, Haynes, 
Grandinetti, & Chang, 2003). This particular outcome may be related to poor control of 
diabetes, such that depressed mood may result in less motivation to properly manage 
diabetes or feelings of hopelessness about one’s ability to manage diabetes. In addition, 
Zhang, Norris, Gregg, Cheng, Beckles, and Kahn (2005) found that severe depressive 
symptoms significantly elevated the risk for mortality among U.S. adults with diabetes.  
One of the more commonly studied diabetes-related outcomes is glycemic 
control. Glycemic control is fundamental to the management of diabetes (American 




glycemic control are self-monitoring of blood glucose by diabetes patients and health 
care providers performing A1C tests every two to three months. Lower A1C levels have 
been associated with lower risk of diabetes-related health complications, including heart 
attacks, cardiovascular-related deaths, and reduction of microvascular and neuropathic 
complications (American Diabetes Association, 2005).  
Research examining the relationship between depression and glycemic control has 
provided mixed results. The results of a meta-analytic investigation of 24 studies 
measuring the association between depression and glycemic control, as indicated by an 
assessment of total glyco-hemoglobin (GHb), suggested that depression was associated 
with poor glycemic control (hyperglycemia) among patients with type 1 and type 2 
diabetes, although the direction of the relationship was not specified (Lustman, Anderson, 
Freedland, de Groot, Carney, and Clouse, 2000). The results of several studies have 
shown a significant relationship between depression and A1C levels in individuals with 
type 1 diabetes, suggesting that the more severe the depression, the worse the glycemic 
control (Ciechanowski, Katon, Russo, & Hirsch, 2003; Lustman, Clouse, Ciechanowski, 
Hirsch, & Freedland, 2005; Pouwer & Snoek, 2001). However, the results of other 
studies have shown no evidence of a relationship between depression and A1C levels in 
persons with type 2 diabetes (Ciechanowski et al., 2000; Ciechanowski et al., 2003; 
Kaholokula et al., 2003; Lee, Chapa, Kao, Jones, Kapustin, et al. 2009). Such a variety of 
findings could be due to most of these studies having a cross-sectional vs. longitudinal 
designs, as well as differences in populations used and covariates examined. 
Recent research suggests that racial and ethnic minorities, particularly members 




non-Hispanic White populations to achieve glycemic control (Fan, Koro, Fedder, & 
Bowlin, 2006; Saydah, Cowie, Eberhardt, DeRekeneire, & Narayan, 2007; Suh,, Choi, 
Plauschinat, Kwon, & Baron, 2010).  A number of factors have been investigated in order 
to better understand and explain this health disparity, including racial and ethnic 
differences in the access to health care and prescription drug coverage, differences in 
preventative care practices, receipt of less optimal care from providers, and biological 
and socioeconomic factors (Kirk, D’Agostino, Bell, Passmore, Bonds, et al., 2006). 
Racial and ethnic differences in depression are another factor potentially 
maintaining the racial and ethnic differences in glycemic control. The relationship 
between depression and glycemic control among racial and ethnic minority populations 
has been investigated in a few studies, with most studies focusing on Black American 
populations. Gary, Crum, Cooper-Patrick, Ford, and Brancati (2000) found that among 
Black Americans with type 2 diabetes, depressive symptoms were marginally associated 
with higher A1C levels, but was significantly associated with higher levels of total 
cholesterol and triglyceride. In an ethnically diverse sample of elderly diabetes patients, 
another study found a weak relationship between depression and A1C, but also found that 
depression did not predict change in glycemic control (Trief, Moin, Izquierdo, Teresi, 
Eimicke, et al., 2006). Recently, Wagner, Abbott, Heapy, and Yong (2009) found that 
higher depressive symptoms were associated with higher A1C, more long-term diabetes 
complications, and more diabetes medications among a sample of Black Americans. The 
findings of these studies suggest a relationship between depression and poor diabetes 




multiple racial and ethnic minority populations are needed to better understand possible 
racial and ethnic differences.  
Generally, depression appears to be related to increased diabetes complications, 
poorer quality of life, and increased mortality risk among patients with diabetes. 
Although the results are mixed, depression also appears to have some relationship to 
glycemic control among patients with diabetes, particularly among Black Americans. 
 Diabetes, Depression, and Sexual Dysfunction 
 Sexual dysfunction is another diabetes-related complication that can potentially 
be associated with both depression and diabetes. Both male and female patients with 
diabetes report difficulties with sexual dysfunction. Estimates of the prevalence of sexual 
dysfunction in women with diabetes range from 18 to 42%, while prevalence estimates of 
erectile dysfunction in men with diabetes ranges from 20 to 75% (National Diabetes 
Information Clearinghouse, 2008).  
Results of a recent review of studies investigating sexual dysfunction in women 
with diabetes revealed that type 2 diabetes seemed to have a greater impact on women’s 
sexuality than type 1 diabetes, which the authors hypothesized may be related to age, 
menopausal status, co-morbid factors, or social and psychological factors (Giraldi and 
Kristensen, 2010). Sexual problems in women with diabetes mostly include lack of 
sexual desire, sexual dissatisfaction, orgasmic disorder, arousal disorder and poor 
lubrication (Bultirini, Carosa, Colpi, Poccia, Iannarelli, et al, 2004). Some research 
findings suggest that neuropathy, vascular impairment, and psychological complaints are 
possible risk factors of female sexual dysfunction in diabetic women (Amaral, Oliveira, 




dysfunction in women with diabetes may be less related to physical diabetes 
complications and more related to psychological factors, including quality of the partner 
relationship and coexisting depression (Enzlin, Mathieu, Van Den Bruel, 
Vanderschueren, & Demyttenaere, 2003; Giraldi & Kristensen, 2010). 
Men who have diabetes are two to three times more likely to have erectile 
dysfunction than men who do not have diabetes, and men with diabetes may experience 
erectile dysfunction as much as 10 to 15 years earlier than men without diabetes (NDIC, 
2008). Research findings suggest that diabetes causes damage to nerves throughout the 
body including the penis, making neuropathy a major risk factor for erectile dysfunction 
(Agostini, Rossi, & Pajalich, 2006; Zdravko, Kamenov, Tsanka, & Yankova, 2007). 
While some research findings suggest that significant risk factors for sexual dysfunction 
in men, but not women, included BMI, duration of diabetes, and diabetic complications 
(Enzlin, 2003), other research findings indicated no major gender differences between 
sexual dysfunction and age, diabetes status, duration of diabetes and hypertension (Ziaei-
Rad, Vahdaninia, & Montazeri, 2010). 
There is very little research estimating the prevalence of sexual dysfunction 
among members of racial and ethnic minority groups in the general population and 
reported rates of sexual dysfunction for men appear to be inconsistent. Laumann, Paik, 
and Rosen (1999) found racial and ethnic differences in the prevalence of sexual 
problems among a sample of 1,410 men and 1,749 women, namely that Black Americans 
appeared more likely than White Americans and non-White Hispanics to have sexual 
problems, and non-White Hispanics appeared less likely to have sexual problems. These 




lack of desire for sex, arousal difficulties, inability to achieve climax or ejaculation, 
anxiety about sexual performance, climaxing or ejaculating too rapidly, physical pain 
during intercourse, and not finding sex pleasurable (Laumann et al., 1999). However, 
Saigal, Wessells, Pace, Schonlau, and Wilt (2006) found among a sample of 3566 men, 
that non-White Hispanic men, younger than 50 years of age, had more than twice the 
prevalence of erectile dysfunction compared with similar non-Hispanic Black and non-
Hispanic White men.  
Another study examining racial and ethnic differences in sexual dysfunction 
among middle-aged women found significant group differences for sexual arousal, pain 
during intercourse, desire, and frequency of sexual intercourse. Specifically, Black 
American women reported higher frequency of sexual intercourse than White American 
women; non-White Hispanic women reported lower physical pleasure and arousal; and 
Chinese women reported more pain and less desire and arousal than the white women, as 
did the Japanese women (Avis, Zhao, Johannes, Ory, Brockwell, & Greendale, 2005).  
Unfortunately, no studies were found that estimated the prevalence of sexual 
dysfunction among members of racial and ethnic minority groups with diabetes, although 
some studies estimated the prevalence of erectile dysfunction among members of racial 
and ethnic minority groups with other chronic diseases, including prostate cancer and 
heart failure (Siegel, Moul, Spevak, Alvord, & Costabile, 2001; Hebert, Lopez, 
Castellanos, Palacio, Tamariz, & Arcement, 2008). Given that diabetes is the leading 
contributor to erectile dysfunction and is also significantly related to sexual dysfunction 
in women, knowledge of racial and ethnic differences in prevalence rates could enhance 




Similar to the literature on the relationship between depression and glycemic 
control, study results regarding a relationship between sexual dysfunction and glycemic 
control are mixed. Only a few studies have examined the relationship between sexual 
dysfunction and glycemic control. Some studies have found no relationship between 
sexual dysfunction and levels of A1C among both genders (Shiri, Ansari, & Hassani, 
2006; Ziaei-Rad et al., 2010). Other studies have identified glycemic control as an 
independent predictor of sexual dysfunction in men (Khatib, Jarrah, Shegem, Bateiha, 
Abu-Ali, & Ajlouni, 2006), while others have found no relationship between glycemic 
control and sexual dysfunction in women (see Giraldi & Kristensen, 2010). Overall, it 
appears that further research is needed to better understand the possible association 
between sexual dysfunction and glycemic control, particularly among men.  
 Sexual dysfunction, specifically loss of interest in sexual activity, is a common 
symptom of depression, and the occurrence of sexual dysfunction appears to be 
consistently higher in patients with depression than in the general population (Kennedy & 
Razvi, 2009). Kennedy, Dickens, Eisfeld, and Bagby (1999) found that among 55 males 
and 79 females diagnosed with major depression, some of the frequently reported sexual 
problems in untreated patients with depression included reduction in sexual desire 
(approximately 40% of men and 50% of women), difficulties with erection/ejaculation 
(22% of men), or difficulties with orgasm (15% of women). Also, it seems that the 
relationship between sexual dysfunction and depression could be bidirectional, in that the 
presence of either one of these conditions may trigger or exacerbate the other (Kennedy 




Patients with diabetes and depression may be particularly vulnerable to the effects 
of sexual dysfunction. However, very few studies have examined the relationship 
between depression and sexual dysfunction among patients with diabetes. Results of a 
recent review of the literature on sexual dysfunction and women with diabetes revealed 
that depression appeared to be a significant risk factor for female sexual dysfunction 
(Giraldi & Kristensen, 2010). Among men with diabetes, the risk of erectile dysfunction 
was found to be higher in those with depression compared to those without depression 
(Shiri et al., 2006); no studies examining racial and ethnic differences were found. Given 
the potential impact depression has on patient management of their diabetes, and the 
increased physical and psychological impact that sexual dysfunction may have on patient 
management of their diabetes, more information is needed regarding the impact of 
depression and sexual dysfunction on diabetes management, particularly on glycemic 
control; racial and ethnic differences also need to be further explored. 
Summary 
 Diabetes prevalence rates are on the rise, particularly among members of racial 
and ethnic minority groups. Patients with diabetes are more vulnerable to developing 
depressive symptoms when compared to those without diabetes, with some racial and 
ethnic differences in treatment and rates of diagnosis. Depression appears to influence the 
relationship to diabetes-related health complications, including glycemic control. Based 
on published studies, there appears to be no racial and ethnic differences in depression 
prevalence estimates among diabetes patients; however, racial and ethnic minorities are 





 One of the many health complications related to diabetes is sexual dysfunction, 
with diabetes patients being more vulnerable to sexual dysfunction than those without 
diabetes. The results of a possible relationship between sexual dysfunction and glycemic 
control are inconsistent, and while there is some research examining racial and ethnic 
differences in the general population, the findings are also inconsistent and there is very 
little research examining racial and ethnic differences in the prevalence of sexual 
dysfunction among individuals with diabetes. Despite the risk of depression among those 
with diabetes and the potential psychological impact of sexual dysfunction, the 
relationship between, and the impact of, depression and sexual dysfunction has received 
very little attention in the diabetes research literature.  
The Current Study 
 This study was designed to address gaps in the diabetes literature by contributing 
more information regarding racial and ethnic differences. Specifically, this study was 
designed to test racial and ethnic differences in the prevalence of depression, and, to the 
best of this author's knowledge, will be one of the first investigations designed to 
examine racial and ethnic differences in sexual dysfunction among men with diabetes. 
The purpose of this study is to explore the potential impact of depression and sexual 
dysfunction on glycemic control among individuals with diabetes, namely if individuals 
with diabetes diagnosed with depression and/or sexual dysfunction (i.e., depression only, 
sexual dysfunction only, or comorbid depression/sexual dysfunction) have more 
difficulties with glycemic control compared to individuals with diabetes who have neither 
disorder. This study was designed to explore the possibility of a longitudinal impact of 




This study is designed to explore these questions using a sample of veterans. 
Diabetes is highly prevalent among veterans. Of 877,775 veterans surveyed by Miller, 
Safford, and Pogach (2004), the prevalence of diabetes among veterans was 19.6% in 
2000, and the annual incidence of diabetes in veterans is approximately 2% per year. 
Diabetes is the third most common diagnosis in the VA system, affecting 25% of 22,645 
VA patients surveyed by Reiber, Au, McDonell, and Fihn (2004).  
Also, the prevalence of depression among veterans with diabetes and the possible 
impact of depression on glycemic control among members of this population have been 
examined in few studies. According to the Veterans Health Administration (VHA) 
External Peer Review Program (EPRP), 85% of  21,489 veterans have received annual 
depression screenings since fiscal year 2004 (Office of Quality Performance, 2006), and 
on average, almost 9% of veterans screen positive for depression (Desai, Rosenheck, & 
Craig, 2006). In regards to glycemic control, one study using a cohort of veterans with 
type 2 diabetes to investigate the longitudinal effects of depression on glycemic control 
found a significant  relationship between depression and glycemic control as measured by 
A1C, and that depression appeared to be associated with persistently higher A1C levels 
over time (Richardson, Egede, Mueller, Echols, & Gebregziabher, 2008). Also, similar to 
the non-veteran population, veterans who are members of racial and ethnic minority 
groups have been found to have poorer glycemic control (higher A1C levels) when 
compared to White American veterans (Egede, Mueller, Echols, & Gebregziabher, 2010). 
Given these findings it may be beneficial to start to explore this study’s research 
questions using a sample of veterans. While this research could improve the overall 




minority veterans, it could also inform possible future investigations of these issues in the 
general diabetes population. The specific research questions and hypotheses are as 
follows: 
 Question 1: Are there racial and ethnic differences in the prevalence rates of 
depression among veterans with diabetes? 
o Hypothesis 1: Consistent with existing literature, there will be racial 
and ethnic differences in rates of depression among veterans with 
diabetes, with White American veterans having higher rates than Black 
American veterans. 
 Question 2: Are there racial and ethnic differences in rates of sexual 
dysfunction among veterans with diabetes?  
o Hypothesis 2: There will be racial and ethnic differences in rates of 
sexual dysfunction, with racial and ethnic minority veterans with 
diabetes having higher rates than White American veterans. 
 Question 3: Are there longitudinal racial and ethnic differences in A1C levels 
(glycemic control) among veterans with diabetes? 
Hypothesis 3: Consistent with existing literature, there will be longitudinal 
racial and ethnic differences in A1C levels, with racial and ethnic minority 
veterans having higher A1C levels compared to White American veterans 
over time. 
 Question 4: Do veterans with diabetes experiencing depression and/or sexual 




compared to diabetic veterans with neither depression nor sexual dysfunction? 
Are there racial and ethnic differences in A1C values? 
o Hypothesis 4: Veterans with diabetes experiencing depression and/or 
sexual dysfunction are expected to have higher A1C levels over time 
compared to veterans with diabetes with neither disorder. Racial and 
ethnic differences are also expected, with members of racial and ethnic 
minority groups having higher A1C levels within each diagnostic 
group. 
Overall, this study will provide more information about the impact of depression 
and sexual dysfunction on veterans with diabetes and their abilities to manage their 
diabetes, while highlighting the possibility of racial and ethnic differences. This research 







The data for this study were extracted from the Veteran’s Affairs (VA) 
Informatics and Computing Infrastructure (VINCI), which is partnered with the 
Corporate Data Warehouse (CDW) and provides VA researchers access to integrated 
national datasets and tools for analysis in a secure, high-performance computing 
environment. The data are accessible to authorized users only, who log onto VINCI via a 
virtual private network connection (VPN) or through a computer on the VA intranet 
through a Secure Gateway. VINCI stores the requested data on a Standard Workspace. 
By Office of Research and Development (ORD) policy, VINCI is not authorized to allow 
the transfer of any patient-level data out of its secure environment without special 
permission. To ensure data security, VINCI created a File Transfer Utility to facilitate all 
data transfers including the transfer of tables and graphics generated as part of routine 
analysis.  
The data for this study entailed records of inpatient and outpatient visits to 
VAMC’s throughout the nation, including primary care visits and specialty care visits. 
The clinical data obtained for this study included: International Classification of 
Diseases, Ninth Edition (ICD-9) diagnostic codes for type 2 diabetes, depression and 




possible comorbid diagnoses of hypertension, coronary heart disease, and stroke; and 
demographic data, including age, race, gender, marital status, and state of residence. 
Study Population 
A national cohort of 105,411 veterans with diabetes who had received a diagnosis 
of depression and/or sexual dysfunction between June 2007 and June 2012 were 
identified. Racial and ethnic groups included were then as non-Hispanic White (NHW), 
non-Hispanic Black (NHB), and Other (Asian, Native Hawaiian/Pacific Islander, and 
Native American/Alaskan Native). There were several collection methods for race 
included in the raw data, including “observer”, “proxy”, “unknown”, or no collection 
method specified. Only veterans with a “self-identification” method associated with race 
were included, as it was deemed to be the most reliable source of race information. It 
should be noted that although non-White Hispanic populations were discussed in the 
Introduction, non-White Hispanic veterans were not clearly identified in this study’s 
sample, likely due to a coding issue in the database; this issue will be discussed further in 
the Discussion. Veterans diagnosed with schizophrenia and/or bipolar disorders were 
excluded from the analyses to be consistent with the overall purpose of the investigation. 
Design and Procedures 
Measures 
Diagnoses of depression and sexual dysfunction were determined based on ICD-9 
codes associated with billable encounters found in patient medical records. In other 
words, diagnoses were determined based on a veteran having at least one clinical 
encounter during which depression or sexual dysfunction was identified as a primary or 




diagnostic categories based on the ICD-9 codes. Veterans with at least one ICD-9 code 
for depression (296.2, 296.3, 296.9, 300.4, 311) were included in the depression only 
group; veterans with at least one ICD-9 code for sexual dysfunction (320, 799.81, V41.7) 
were included in the sexual dysfunction only group; veterans with at least one ICD-9 
code for both depression and sexual dysfunction were included in the comorbid 
depression/sexual dysfunction group; and veterans with no ICD-9 code for either 
depression or sexual dysfunction were included in the no diagnosis group. 
For this study, glycemic control was defined by lab test results for hemoglobin 
A1C. A1C test results show a patient’s average blood sugar level over time. The result is 
reported as a percentage. The American Diabetes Association (ADA) recommends that 
diabetes patients keep their A1C levels less than 7%, which is considered normal 
glycemic control; an A1C level greater than 8% is considered poor glycemic control. 
(ADA, 2005). Results of lab test data for A1C in a given 3-month time interval was 
extracted from patient medical records. The 3-month interval was chosen because A1C 
levels are generally measured every three months, which is the approximate lifespan of 
the red blood cells that store blood glucose information. For patients with two or more 
A1C values in a given 3- month time interval, the most recent A1C value for that interval 
was used as it would include the most recent blood glucose information stored in the red 
blood cells.  
Data Analytic Strategy. 
Several analyses were conducted to obtain descriptive statistics and to test the 
study hypotheses. Descriptive information was obtained by comparing demographic and 




revealed that females and members of the “Other” racial and ethnic group comprised only 
small percentages of the total sample at 7% and 5%, respectively. These groups were 
removed from further study analyses, due to the difficulty of making meaningful 
statistical inferences about these populations given the small sample sizes and the 
heterogeneity of the ‘Other’ racial and ethnic group. 
 The age range for the participants in the sample was large (i.e., 23-years-old to 
103-years-old), which highlights the heterogeneity of the sample. Given this study’s 
accelerated longitudinal design, it is standard procedure to rescale the ‘Time’ variable to 
age, which models participants to enter and leave the study at different times as opposed 
to modeling them all as covering the same time in each participant’s lives. To rescale 
time to age, a person–period dataset was created for each patient to cover 3-month 
intervals from June 2007 to June 2012 to correspond with patient A1C results data. Each 
3-month interval was then assigned a corresponding number to create the time variable 
‘Time-Period’ (i.e., June 2007 = Time-Period 0). The ‘Time-Period’ values and the 
minimum age for the sample (23-years-old) were then used to create a new time variable 
accounting for age, ‘Time’, using the following formula: Time= ((Patient Age – 23) + 
(.25*Time-Period))/Constant. The normality of the distribution of the newly created time 
variable was assessed and while the distribution was found to be normal, the tail ends of 
the distribution were long. Cases below the 25
th
 and above the 75
th
 percentiles were 
dropped to remove the extreme cases from the study, leaving 52,039 patients in the final 
study sample.  
To examine racial and ethnic differences in the rates of depression and sexual 




dysfunction diagnoses by racial and ethnic group were conducted. General linear mixed 
models were used to test hypotheses 3 and 4.  To address hypothesis 3, a general linear 
model was conducted to compare unadjusted mean A1C values across all time points for 
each of the racial and ethnic groups. Next, a linear mixed model approach was used to 
model the relationship between A1C levels as a continuous variable and race and 
ethnicity over time. The model included A1C as the dependent variable (y), and race (x) 
and time (t) as primary variables of interest, and the interaction between x and t (y on x, t, 
and x*t).  
Similar procedures were used to examine A1C levels over time among veterans 
with diabetes in the four diagnostic groups (Hypothesis 4). Again, a general linear model 
approach was used to compare unadjusted mean A1C values across all time points, this 
time for each of the depressed/sexual dysfunction diagnostic groups, and a general linear 
mixed model approach was used to examine changes over time in A1C levels among the 
different depressed/sexual dysfunction diagnostic groups, as well as to explore possible 
racial and ethnic differences in A1C levels within diagnostic groups. Model building 
occurred in a hierarchical fashion. The first linear model contained A1C as a dependent 
variable (y), and diagnostic group (x) and time (t) as the primary fixed effects of interest. 
Thus, the first model included x, t, and the interaction between x and t (y on x, t, and x*t). 
To examine possible racial and ethnic differences within diagnostic groups, a second 
linear fitted with the diagnostic group as a primary fixed effect of interest and race as a 
further adjustment variable (y on x, t, and race), along with the interaction term between 
race  and the diagnostic group (y on x, t, race, and x*race). A final model was fitted to 




groups. All models contained a person-level random effect to account for correlation of 
A1C values within individuals. Also, least square means were obtained from all models 
to compare adjusted mean A1C values for the different diagnostic groups. All statistical 




Table 2.1- Original sample demographic and clinical characteristics 











































Sex (%)      
 Male 91.5 99.9 99.3 95.5 93.4 
 Female 8.5 0.11 0.68 4.55 6.6 
Race/ethnicity (%)      
 Black 13.7 25.3 22.8 15.0 15.9 
 White 81.5 69.1 72.0 79.6 79.3 
 Other 4.7 5.3 5.2 5.4 4.9 
Marital Status (%)      
 Never Married 8.3 6.4 6.1 8.4 7.9 
 Married 54.0 55.0 57.2 51.7 54.5 
 Separated 3.4 3.7 4.4 3.2 3.6 
 Divorced 25.3 28.7 26.4 26.2 25.6 
 Widowed 9.1 6.2 5.8 10.5 8.5 
Hypertension (%) 91.0 93.6 93.8 90.0 91.5 
Heart Disease (%) 48.5 50.1 48.2 52.9 48.8 






This study included data from a national sample of 52,039 veterans. The mean 
age was 66-years-old (M = 66.0, SD = 2.80), with ages ranging from 60 to 70-years-old, 
and 59% of the sample self-identified as married. Eighty-six percent (86%) were White 
American and 15% were Black American. Sixty-eight percent (68%) had been diagnosed 
with depression only, 2% with sexual dysfunction only, 24% with comorbid 
depression/sexual dysfunction, and 6% had neither diagnosis. See Table 3.1 for additional 
demographic information for the sample. 
Hypotheses 1 & 2: Depression and Sexual Dysfunction Prevalence 
Chi-square results revealed racial and ethnic differences in the prevalence of 
depression among veterans with diabetes [
2
 (2, N = 52,039) = 30.64, p < .0001], with 
White American veterans having higher rates of depression (91%) than Black American 
veterans (90%). However, the effect size for this analysis was small (phi = .02), which 
suggest that despite the statistical significance of the Chi-square finding, the overall 
differences in depression rates between White American veterans and Black American 
veterans was not large. Chi-square results also revealed significant racial and ethnic 
differences in the prevalence of sexual dysfunction [
2 
(2, N = 52,039) = 721.06, p < 
.0001], with Black American veterans having higher rates of sexual dysfunction (38%) 
than White American veterans (24%). The effect size for this analysis was also small (phi 




the overall differences in sexual dysfunction rates between Black American veterans and 
White American veterans was also not large. 
Hypothesis 3: Racial and Ethnic Differences in A1C Levels over Time 
Table 3.2 shows the results for examining racial and ethnic differences in changes 
in A1C levels over time. Results indicate there was a significant race-by-time interaction 
(β= -.30, t (51,997) = -5.77, p <.0001), indicating a significant difference in the changes 
of mean A1C levels over time between White American and Black American veterans. 
Figure 3.1 depicts these mean changes in A1C levels over time, demonstrating a decrease 
in mean A1C levels for Black American veterans as age increases, whereas mean A1C 
levels for White Americans increased in relation to an increase in age. Specifically, the 
mean A1C level for Black American veterans decreased from about 7.3% at age 60 to 
about 7.2% by age 74. Conversely, the mean A1C level for White American veterans 
increased from about 7.1% at age 60 to about 7.2% by age 74. 
Hypothesis 4: Diagnostic Group Differences in A1C Levels over Time  
Table 3.3 shows the results of Model 1 with A1C level as the dependent variable 
and diagnostic group as independent variable (adjusted for time). Results indicate a 
significant difference in A1C levels between veterans with a diagnosis of depression 
and/or sexual dysfunction and those without either diagnosis. Specifically, veterans with 
sexual dysfunction only had significantly higher A1C levels when compared to veterans 
with no diagnoses of depression or sexual dysfunction (β= .13, t (51,996) = 2.79, p = .01). 
Least square mean results for this model indicate a statistically significant mean 
difference in A1C levels between veterans with sexual dysfunction and those with no 




percentage points higher than A1C levels for veterans with no diagnosis (95% CI [0.03, 
0.12], p = 0.001). Additionally, there were no significant diagnostic group-by-time 
interactions, indicating that there were no significant differences in the changes of mean 
A1C values as veterans within each diagnostic group increased in age (Figure 3.2). 
A second model was run to examine possible racial and ethnic differences in A1C 
levels within each diagnostic group over time. Table 3.4 shows the results of Model 2 
with A1C as the dependent variable and race and diagnostic group as independent 
variables (adjusted for time). Results revealed a significant race*group*time interaction 
for veterans in the depression group (β= -0.42, t (51,996) = -2.02, p = .04), indicating a 
significant difference in the changes of mean A1C levels over time between Black 
American veterans and White American veterans diagnosed with depression. Figure 3.3 
presents these mean changes in A1C levels over time, demonstrating a decrease in mean 
A1C levels for Black American veterans diagnosed with depression as age increases, 
whereas mean A1C levels for White American veterans with depression increased in 
relation to an increase in age. Specifically, the mean A1C level for Black American 
veterans with depression decreased from about 7.3% at age 60 to about 7.2% by age 74. 
Conversely, the mean A1C level for White American veterans with depression increased 
from about 7.1% at age 60 to about 7.2% by age 74. 
Building on Model 2, a third model was run to examine the impact of additional 
disease co-morbidities on possible racial and ethnic differences in A1C levels within each 
diagnostic group over time. Table 3.5 shows the results of Model 3 with A1C as the 
dependent variable, race and diagnostic group as independent variables (adjusted for 




covariates. Results revealed that the significant race*depression*time interaction found in 
Model 2 was maintained in this model (β= -.43, t (50,564) = -2.05, p = .04). Figure 3.4 
presents these mean changes in A1C levels over time, demonstrating the same trend 
found in Model 2: a decrease in mean A1C levels for Black American veterans diagnosed 
with depression from about 7.3% at age 60 to about 7.2% by age 74 and an increase in 
mean A1C levels for White American veterans with depression from about 7.1% at age 
60 to about 7.2% by age 74. 
Post-hoc Analyses: Assessing for Curvilinear Trajectories 
 Upon closer analysis of the simple slopes for the linear model analyses, it seemed 
important to assess for possible curvilinear trajectories in the data. The linear modeling 
results suggested that A1C levels for veterans with diabetes gradually increased for White 
American veterans or decreased for Black American veterans as they get older. However, 
it’s possible that the change in A1C over time is better understood as a curvilinear 
relationship, such that A1C levels should reach and optimal level (i.e., less than 7% for 
individuals with diabetes), and then stabilize rather than continue to increase or decrease 
as they get older. A curvilinear model may also provide more accurate information 
regarding the rate of change in A1C levels over time. For example, an individual newly 
diagnosed with diabetes could have a more rapid improvement in A1C levels initially as 
they take more deliberate steps to maintain healthy blood sugar levels, but then the rate of 
change slows as A1C levels begin to stabilize, assuming the individual’s blood sugar 
levels remain under control.  
Given the possible real-life trajectories for change in A1C levels, new analyses 




quadratic modeling. Specifically, while the previously tested linear model for racial and 
ethnic differences in A1C levels over time included A1C as the dependent variable (y), 
and race (x) and time (t) as primary variables of interest, and the interaction between x 
and t (y on x, t, and x*t), the non-linear model included A1C as the dependent variable 
(y), and race (x), time (t), and the quadratic term for time (t
2
) as primary variables of 
interest, and the interactions between x, t, and t
2





The same modeling procedure was used for exploring a quadratic relationship for 
changes in A1C levels over time for veterans with depression and/or sexual dysfunction 




), and possible racial and ethnic differences in A1C levels 






, race*x*t, and race*x*t
2
). 
All models included a person level random effect to account for within-individual 
correlations of A1C values. Because t and t
2
 are highly correlated, contrast tests for each 
two, three, and four-way interaction with the t or t
2
 term were conducted as well as a 
contrast test for the goodness of fit for the quadratic model. 
Results for Curvilinear Modeling 
Racial and ethnic differences in A1C levels over time. 
Table 3.6 shows the results for examining a curvilinear relationship for racial and 
ethnic differences in changes in A1C levels over time. Results indicate that there was a 
significant contrast test for race*t and race*t
2
, indicating that race had a significant effect 
on A1C levels over time (p < 0.001). The contrast testing for improvement in goodness of 
fit of the quadratic modeling was also significant (p < 0.001), indicating the quadratic 
modeling of this analysis was a better fit than the linear modeling. Figure 3.5 depicts 




appeared to start with higher mean A1C levels that seemed to peak at a younger age 
before they began to gradually decrease. Mean A1C levels for White American veterans 
started lower and peaked and plateau at a later age compared to Black American veterans. 
Specifically, analyses revealed mean A1C levels for Black American veterans was 7.28% 
at age 60, peaked at 7.30% around age 62, and then decreased to 7.18% by age 74. The 
mean A1C level for White American veterans was 7.02% at age 60, peaked at 7.20% 
around age 68, and still remained at this level by age 74. 
 Diagnostic group differences in A1C levels over time 
Table 3.7 shows the results for examining a curvilinear relationship for diagnostic 
group differences in changes in A1C levels over time (Model 1.2). Results revealed 
significant contrasts for sex dysfunction*time and sex dysfunction*time
2
 (p = .0003) as 
well as for depression*sex dysfunction*time and depression*sex dysfunction*time
2
 (p = 
.001). The significant contrasts indicate that veterans with sexual dysfunction and 
veterans with both depression/sexual dysfunction had significantly different changes in 
mean A1C levels over time compared to veterans with no diagnosis. The contrast testing 
for improvement in goodness of fit of the quadratic modeling was also significant (p < 
0.001), indicating the quadratic modeling of this analysis was a better fit than the linear 
modeling. Figure 3.6 depicts mean changes in A1C levels over time. Specifically, A1C 
levels for veterans with only sexual dysfunction appeared to start higher than those for 
veterans with no diagnosis, but they also peaked at an earlier age and decreased more 
rapidly than A1C levels for veterans with no diagnosis. Additionally, A1C levels for 
veterans with both depression/sexual dysfunction appeared to start at levels similar to the 




the no diagnosis group.  Specifically, the mean A1C levels for veterans with only sexual 
dysfunction was about 7.20% at age 60, peaked at 7.35% around age 62, and then 
decreased to about 7.04% by age 74. The mean A1C level for veterans with both 
depression/sexual dysfunction was about 7.06% at age 60, peaked at 7.25% around age 
68, and still remained at this level by age 74. The mean A1C level for veterans with no 
diagnosis was about 7.06% at age 60, peaked at 7.20% around age 68, and still remained 
at this level by age 74.  
Table 3.8 shows the results of the model examining a possible curvilinear 
relationship for racial and ethnic differences in A1C levels within each diagnostic group 
over time (Model 2.2). Results, revealed that the significant contrasts found in Model 1.2 
were maintained, sex dysfunction*time and sex dysfunction*t
2
 (p = .01) and 
depression*sex dysfunction*t and depression*sex dysfunction*t
2
 (p = .02). However, 
there were no significant contrasts for any of the race*group categories over time, 
suggesting that there are no racial and ethnic differences in the patterns of change in A1C 
among veterans diagnosed with depression and/or sexual dysfunction. There was also no 
significant contrast for testing improvement in goodness of fit of the quadratic modeling 
(p = .11), indicating that the quadratic modeling was not a better fit for this analysis when 
compared to the linear modeling.  
Table 3.9 shows the curvilinear modeling results for racial and ethnic differences 
in A1C levels among veterans with depression and/or sexual dysfunction after adjusting 
for additional covariates of hypertension, coronary heart disease, and history of a stroke 
(Model 3.2). Results reflect significant main effects for hypertension and coronary heart 




the significant contrasts for sexual dysfunction (p = .01) and comorbid depression/sexual 
dysfunction (p = .02) were sustained in this model. Again, here was also no significant 
contrast for the goodness of fit of the quadratic modeling (p = .07), indicating that the 





Table 3.1- Final sample demographic and clinical characteristics 
 








N  35,328 
(68%) 
1,054 (2%) 12,350 
(24%) 
3,307 (6%) 52,039 
Mean A1C values 
(S.D.) 
7.20 (1.48) 7.43 (1.54) 7.35 (1.49) 7.27 (1.48) 7.31 
(2.81) 
Mean age in years 
(S.D.) 
66.0 (2.81)  66.1 (2.75) 65.9 (2.73) 66.2 (2.86) 66.0 
(2.80) 
Race/ethnicity (%)      
 Black 12.3 25.6 21.9 15.5 15.1 
 White 87.7 74.4 78.1 84.5 85.9 
Marital Status (%)      
 Never Married 6.9 5.5 5.0 8.1 6.5 
 Married 58.7 57.6 59.9 52.8 58.6 
 Separated 3.1 2.8 3.9 3.6 3.3 
 Divorced 26.5 29.6 26.5 30.7 26.8 
 Widowed 4.9 4.6 4.6 4.8 4.8 
Hypertension (%) 92.6 94.5 94.8 90.1 93.0 
Heart Disease (%) 49.7 50.3 50.1 53.0 50.0 






Table 3.2- Fixed effect estimates for changes in A1C values across racial groups over 
time. 
 
 Beta coefficient 
estimate 
Standard Error P-value 
Intercept (ref. = NHW) 7.14 0.01 <.0001*** 
Non-Hispanic Black 0.11 0.01 <.0001*** 
Time 0.22 0.02 <.0001*** 
Non-Hispanic Black*Time -0.30 0.05 <.0001*** 













Table 3.3- Fixed effect estimates for changes in A1C values across diagnostic groups 
over time (Model 1). 
  





Intercept (ref. = No diagnosis) 7.17 0.02 <.0001*** 
Depression  -0.02 0.02 0.37 
Sexual Dysfunction 0.13 0.05 0.01* 
Depression/Sex Dysfunction 0.07 0.05 0.13 
Time 0.09 0.08 0.25 
Depression*Time 0.10 0.08 0.23 
Sexual Dysfunction*Time -0.28 0.15 0.06 
Depress/Sex Dys*Time 0.29 0.15 0.06 











Table 3.4- Fixed effect estimates for racial differences in A1C values within diagnostic 
groups (Model 2). 
 





Intercept (ref.= No diagnosis, 
White) 
7.14 0.02 <.0001**** 
Non Hispanic Black 0.23 0.06 0.01** 
Depression -0.003 0.03 0.89 
Sex Dysfunction 0.09 0.05 0.08 
Depression/Sex Dysfunction -0.06 0.05 0.29 
Time -0.01 0.08 0.93 
NHB*Depression -0.14 0.06 0.03* 
NHB*Sex Dysfunction -0.04 0.11 0.73 
NHB*Depress/Sex Dys 0.06 0.11 0.58 
Black*Time 0.16 0.20 0.43 
Depression*Time 0.12 0.08 0.14 
Sex Dysfunction*Time -0.39 0.16 0.01* 
Depress/Sex Dys* Time 0.39 0.16 0.02* 
Depression*Black*Time -0.42 0.21 0.04* 
Sex Dysfunction*Black*Time 0.02 0.34 0.94 
Depress/Sex Dys* Black*Time -0.05 0.36 0.88 









Figure 3.3- Racial and ethnic mean changes in A1C levels over time for veterans with 




Table 3.5- Fixed effect estimates for racial differences in changes in A1C levels within 
diagnostic groups with covariates (Model 3)  
 
 Beta coefficient 
estimate 
Standard Error P-value 
Intercept (ref.= No diagnosis, 
White) 
7.14 0.02 <.0001**** 
Hypertension  0.27 0.02 <.0001**** 
CHD  0.15 0.01 <.0001**** 
Stroke  0.0002 0.01 0.99 
Non Hispanic Black 0.24 0.06 <.0001**** 
Depression -0.002 0.02 0.93 
Sex Dysfunction 0.09 0.05 0.09 
Depression/Sex Dysfunction -0.06 0.05 0.27 
Time -0.04 0.08 0.63 
NHB*Depression -0.14 0.06 0.26 
NHB*Sex Dysfunction -0.04 0.11 0.72 
NHB*Depress/Sex Dys 0.06 0.11 0.57 
Black*Time 0.16 0.20 0.41 
Depression*Time 0.13 0.08 0.11 
Sex Dysfunction*Time -0.37 0.15 0.02* 
Depress/Sex Dys* Time 0.37 0.16 0.02* 
Depression*Black*Time -0.43 0.21 0.04* 
Sex Dysfunction*Black*Time 0.01 0.34 0.99 
Depress/Sex Dys* Black*Time -0.02 0.35 0.95 









Figure 3.4- Racial and ethnic mean changes in A1C levels over time for 




Table 3.6- Fixed effect estimates for curvilinear modeling of A1C values across racial 
groups over time 
 





Intercept (ref. = NHW) 7.16 0.01 <.0001*** 
Non-Hispanic Black 0.12 0.02 <.0001*** 
Time 0.23 .02 <.0001*** 
Time
2
 -0.33 0.06 <.0001*** 
Non-Hispanic Black*Time -.032 0.05 <.0001*** 
Non-Hispanic Black*Time
2
 -0.04 0.15 .81 





Figure 3.5- Curvilinear Modeling of Mean changes in A1C levels over time for Black 




Table 3.7- Fixed effect estimates for curvilinear modeling of changes in A1C values 
across diagnostic groups over time (Model 1.2). 
  





Intercept (ref. = No diagnosis) 7.18 0.02 <.0001**** 
Depression  -0.03 0.02 0.30 
Sexual Dysfunction 0.15 0.05 0.002** 
Depression/Sex Dysfunction 0.10 0.05 0.06 
Time 0.19 0.06 0.001** 
Time
2
 -0.30 0.18 0.10 
Depression*Time 0.05 0.06 0.41 
Depression*Time
2
 0.10 0.19 0.58 
Sexual Dysfunction*Time -0.30 0.11 0.01* 
Sexual Dysfunction*Time
2
 -0.94 0.35 0.01* 
Depress/Sex Dys*Time 0.32 0.11 0.01* 
Depress/Sex Dys*Time
2
 0.80 0.36 0.03* 




Figure 3.6- Curvilinear modeling of mean changes in A1C levels over time for veterans 




Table 3.8- Fixed effect estimates for curvilinear modeling of racial differences in A1C 
values within diagnostic groups (Model 2.2). 
 





Intercept (ref.= No diagnosis, 
White) 
7.13 0.03 <.0001**** 
Non Hispanic Black 0.25 0.07 0.01* 
Depression 0.01 0.03 0.79 
Sex Dysfunction 0.15 0.06 0.01* 
Depression/Sex Dysfunction -0.11 0.06 0.07 
Time -0.02 0.08 0.93 
Time
2
 0.09 0.25 0.71 
NHB*Depression -0.18 0.08 0.02* 
NHB*Sex Dysfunction -0.05 0.13 0.68 
NHB*Depress/Sex Dys 0.08 0.13 0.54 
Black*Time 0.18 0.20 0.37 
Black* Time
2
 -.031 0.66 0.63 
Depression*Time 0.13 0.08 0.11 
Depression* Time
2
 -0.19 0.27 0.47 
Sex Dysfunction*Time -0.28 0.17 0.01* 
Sex Dysfunction* Time
2
 -1.06 0.53 0.05 
Depress/Sex Dys* Time 0.29 0.17 0.08 
Depress/Sex Dys* Time
2
 0.90 0.55 0.10 
Depression*Black*Time -0.47 0.21 0.02* 
Depression*Black* Time
2
 0.62 0.70 0.37 
Sex Dysfunction*Black*Time -0.02 0.35 0.94 
Sex Dysfunction*Black* Time
2
 0.16 1.13 0.88 
Depress/Sex Dys* Black*Time 0.002 0.37 0.10 
Depress/Sex Dys* Black* Time
2
 -0.26 1.18 0.82 




Table 3.9- Fixed effect estimates for curvilinear modeling of racial differences in changes 
in A1C levels within diagnostic groups with covariates (Model 3.2)  
 





Intercept (ref.= No diagnosis, 
White) 
7.14 0.03 <.0001* 
Hypertension (ref.= HiBP) 0.27 0.02 <.0001*** 
CHD (ref.= CHD) 0.15 0.01 <.0001*** 
Stroke (ref.= Stroke) 0.001 0.01 0.96 
Non Hispanic Black 0.25 0.07 0.0004*** 
Depression 0.01 0.01 0.79 
Sex Dysfunction 0.15 0.06 0.01* 
Depression/Sex Dysfunction -0.11 0.06 0.07 
Time -0.04 0.08 0.61 
Time
2
 0.05 0.25 0.84 
NHB*Depression -0.18 0.08 0.02* 
NHB*Sex Dysfunction -0.05 0.13 0.68 
NHB*Depress/Sex Dys 0.08 0.13 0.53 
Black*Time 0.18 0.20 0.37 
Black* Time
2
 -.030 0.66 0.65 
Depression*Time 0.14 0.08 0.09 
Depression* Time
2
 -0.17 0.27 0.52 
Sex Dysfunction*Time -0.27 0.17 0.11 
Sex Dysfunction* Time
2
 -1.03 0.53 0.05 
Depress/Sex Dys* Time 0.28 0.17 0.10 
Depress/Sex Dys* Time
2
 0.90 0.55 0.10 
Depression*Black*Time -0.47 0.21 0.03* 
Depression*Black* Time
2
 0.60 0.70 0.39 
Sex Dysfunction*Black*Time -0.04 0.35 0.90 
Sex Dysfunction*Black* Time
2
 0.15 1.13 0.89 
Depress/Sex Dys* Black*Time 0.03 0.37 0.94 
Depress/Sex Dys* Black* Time
2
 -0.24 1.19 0.84 











This study was designed to address gaps in diabetes literature by testing racial and 
ethnic differences in the effects of sexual dysfunction and depression on glycemic control 
over time.  Given the high prevalence of diabetes among veterans, this study examined 
research questions using a sample of veterans.  To the best of this author's knowledge, 
this study was one of the first investigations designed to examine racial and ethnic 
differences in sexual dysfunction among men with diabetes. A strength of this 
investigation was the testing of both linear and curvilinear relationships for racial and 
ethnic differences in glycemic control and the impact of depression and sexual 
dysfunction on glycemic control over time. This is an important contribution to the 
literature since existing research appears to reflect tests of linear relationships. Quadratic 
modeling was found to be a better fit for analyses examining racial and ethnic differences 
in A1C levels over time, as well as for analyses examining differences in A1C levels over 
time between the four diagnostic groups. However, quadratic model was not found to be 
a better fit for analyses examining racial and ethnic differences in the impact of 
depression and/or sexual dysfunction on glycemic control over time.  
Explanation of Findings 
Racial Differences in the Prevalence of Depression. 
It was expected that the results of testing Hypothesis 1 would reveal racial and 




White American veterans would have higher rates of depression than Black American 
veterans, which would be consistent with existing literature. The results of this study 
revealed significant racial and ethnic differences in prevalence of depression among this 
national sample of veterans with diabetes, with White American veterans exhibiting 
higher rates of depression than Black American veterans. These findings could be a 
reflection of racial differences in the detection and diagnosis of depression seen among 
Black and White Americans in the general population. Research suggests that Black 
Americans tend to endorse more somatic rather than affective symptoms of depression 
(Baker, Okwumabua, Philipose, & Wong, 1996; Brown, Schulberg, & Madonia, 1996; 
Das, Olfson, McCurtis, & Weissman, 2006), which could reduce accurate detection and 
diagnosis of depression among Black American veterans with diabetes. Lower rates of 
depression among Black American veterans could also be indicative of lower rates of 
reporting due to culturally-specific beliefs and attitudes about depression. Egede (2002) 
found that perceived stigma and misconceptions about the etiology of depression among 
Black Americans with diabetes were significant barriers to this population seeking 
treatment for depression or adhering to treatment recommendations. Beliefs that 
depression is due to “personal weakness” or “self-pity” are not only barriers to treatment, 
but can also prevent Black Americans from disclosing depressive symptoms to their 
health care providers (Egede, 2002). It should be noted that while these findings were 
significant, the small effect sizes for the analyses (phi = .02) may suggest that the overall 






Racial Differences in Prevalence of Sexual Dysfunction  
It was expected that the test of Hypothesis 2 would reveal racial and ethnic 
differences in rates of sexual dysfunction, with Black American veterans with diabetes 
possessing higher rates. The results of this study supported this hypothesis, with Black 
American veterans exhibiting higher rates of sexual dysfunction than White Americans 
veterans. Existing literature suggest that Black Americans report more problems with 
sexual dysfunction compared to White Americans (Laumann, et. al, 1999). Existing 
literature also indicates that men with diabetes more likely to have erectile dysfunction 
than men who do not have diabetes (NDIC, 2008). Therefore, it seems possible that 
Black American veterans with diabetes would be at greater risk for developing sexual 
dysfunction when compared to White American veterans. Also, Black American veterans 
had higher A1C levels compared to White American veterans, which suggest that they 
are at greater risk for developing other diabetes-health related complications.  It is also 
possible that higher rates of sexual dysfunction among Black American veterans could be 
indicative of depression. As previously mentioned, Black American men tend to report 
more somatic symptoms of depression and may be more likely to report difficulties with 
sexual dysfunction rather than depressed mood. Additional research examining a possible 
relationship between the symptom presentation of depression and sexual dysfunction for 
Black American men is needed. 
Linear and Quadratic Modeling of Racial Differences in Glycemic Control over Time 
Based on existing literature, it was expected that longitudinal racial and ethnic 
differences in A1C levels would be found, with Black American veterans having higher 




this study revealed that while A1C levels for Black American veterans started at higher 
levels compared to White American veterans, A1C levels gradually increased for White 
American veterans and decreased for Black American veterans as they grew older. The 
linear model for changes in A1C levels over time suggested that A1C levels would 
continue to increase for White American veterans as they grew older and continue to 
decrease for Black American veterans as they grew older. However, improvement in 
goodness-of-fit testing revealed that changes in A1C levels over time between Black and 
White American veterans were better understood as a quadratic relationship rather than a 
linear relationship.  
The findings for the quadratic modeling were similar to the findings for the linear 
model, such that A1C levels started higher and decreased for Black American veterans 
and A1C levels started lower and increased for White American veterans. However, the 
quadratic modeling provided more specific information about the different patterns of 
change in A1C levels between Black and White American veterans. Specifically, the 
linear model did not capture the peak in A1C levels for Black American veterans before 
they began to decrease, nor did the linear model capture the peak/plateau of A1C levels 
for White American veterans at a later age compared to Black American veterans. 
Existing research suggests that there are three factors that independently predict change 
in A1C levels over time. Specifically, older age and having diabetes longer significantly 
predict decreases in A1C levels over time, while co-morbid health conditions 
significantly predict increases in A1C levels over time (Fisher, Mullan, Arean, Glasgow, 
Hessler, & Masharani, 2010). These differing patterns of change in A1C levels for Black 




diagnosed with diabetes at an earlier age than White American veterans, and thus their 
A1C levels began to decrease and stabilize at an earlier age as well. These findings also 
suggested that White American veterans may continue to have difficulties reaching 
stabilized A1C levels as they get older, which could be complicated by co-morbid health 
conditions related to the natural process of aging. Findings for a recent population-based 
study found no racial and ethnic differences in age of diagnoses of diabetes; however, it 
was noted that racial and ethnic differences in age of diagnosis were found in previous 
population-based studies, with Black Americans being diagnosed at younger ages than 
White Americans (Koopman, Mainous, Diaz, & Geesey, 2005). This study’s results could 
be a reflection of this pattern.  
It is important to note that A1C levels for White American veterans were still 
lower than those of Black American veterans overall and even peaked at a lower A1C 
level than Black American veterans, suggesting that they may be able to maintain 
glycemic control for a longer period of time than Black American veterans. These 
findings were partially consistent with existing research suggesting that Black Americans 
tend to have higher A1C levels than White Americans (Egede et al, 2010; Fan, et al., 
2006; Saydah, et al., 2007; Suh, et al., 2010). However, this study’s findings revealed 
that as both Black and White American veterans grew older, the differences in A1C 
levels seemed to disappear, such that both groups were trending towards lower A1C 






Linear and Quadratic Modeling of Longitudinal Impact of Depression and Sexual 
Dysfunction on Glycemic Control 
It was expected that veterans with diabetes experiencing depression and/or sexual 
dysfunction would have higher A1C levels over time compared to veterans with diabetes 
with neither disorder. Linear modeling results revealed that veterans diagnosed with only 
sexual dysfunction had significantly different levels and rates of change in A1C levels as 
they grew older. Specifically, veterans with sexual dysfunction had higher A1C levels 
than veterans with no diagnosis, but A1C levels for veterans with sexual dysfunction 
decreased as they grew older and increased for veterans with no diagnosis.  
However, improvement in goodness-of-fit testing revealed that changes in A1C 
levels over time between veterans diagnosed with depression and/or sexual dysfunction 
were better understood as a quadratic relationship rather than a linear relationship. 
Similar to the linear modeling results, quadratic modeling results also revealed a 
significant impact of sexual dysfunction on glycemic control, such that A1C levels for 
veterans with sexual dysfunction started higher, but decreased with age relative to A1C 
levels for veterans with no diagnosis starting lower and increasing with age. Quadratic 
modeling provided more specific information about these changes in A1C levels over 
time. Specifically, compared to mean A1C levels for veterans with no diagnosis, mean 
A1C levels for veterans with sexual dysfunction started higher, peaked, and then began to 
decrease as they grew older. Given research suggesting that having diabetes longer is a 
significant predictor of decreasing A1C levels (Fisher et al., 2010), it seems possible that 
veterans diagnosed with sexual dysfunction are potentially diagnosed with diabetes at a 




peaked and began to decrease at a younger age. A sexual dysfunction diagnosis at a 
younger age can have a significant psycho-social impact on how individuals with 
diabetes manage their illness. Specifically, sexual dysfunction can impact mood and 
decrease motivation for individuals with diabetes to adhere to strict diet and exercise 
regimens necessary to maintain health blood sugar levels, thus decreasing glycemic 
control. A sexual dysfunction diagnosis can also serve as an indicator of poor glycemic 
control. It may be reflective of more difficulties with neuropathic issues, which are likely 
more severe for veterans with higher A1C levels, or poor glycemic control. The 
downward trend in A1C levels among veterans diagnosed with sexual dysfunction could 
be related to having the diagnosis for a long period of time and therefore having a longer 
period to treat and learn to better manage their diabetes and any difficulties with sexual 
dysfunction. 
Quadratic modeling results also revealed a moderately significant impact of co-
morbid depression/sexual dysfunction on glycemic control. A1C levels for veterans with 
both depression and sexual dysfunction followed a similar gradually increasing trend as 
veterans with no diagnosis, but seemed to peak/plateau at a slightly higher A1C level 
than veterans with no diagnosis. Given research indicating that having a number of health 
complications in addition to diabetes is related to increasing A1C levels over time (Fisher 
et al., 2012), is it possible that the additional struggles with depression and sexual 
dysfunction makes managing diabetes somewhat more difficult for this diagnostic group, 
leading in to slightly higher A1C levels compared to veterans with no diagnosis. 
However, it should also be noted that while these findings were significant, the small 




(7.25% at age 74) and veterans with no diagnosis (7.20% at age 74) suggest that the 
overall size of the effect may be smaller. Additional research is needed to determine 
overall clinical significance. 
Linear and Quadratic Modeling of Racial and Ethnic Differences on Impact of 
Depression and Sexual Dysfunction on Glycemic Control over Time 
This study also explored possible racial and ethnic differences in the effects of 
depression and sexual dysfunction on glycemic control over time.  Linear modeling 
results indicated that Black American veterans with depression had higher A1C levels 
that decreased as they grew older, whereas White American veterans with depression had 
lower A1C levels that increased as they grew older. These findings were maintained after 
controlling for other illnesses significantly associated with diabetes, namely 
hypertension, heart disease, and history of stroke. Improvement in goodness-of-fit testing 
indicated that the quadratic modeling for this analysis, with and without the covariates, 
was not a better fit for the data when compared to linear modeling. The results of the 
linear modeling seem to follow the same overall trend found in racial differences in mean 
A1C change over time, specifically Black American veterans having higher A1C levels 
that decreased and White American veterans having lower A1C levels that increased as 
they grew older. Given that research on the impact of depression on A1C levels suggest 
only small to moderate effects over time (Lustman et al, 2000), these significant 
differences in mean A1C change over time among this sample of veterans with 
depression, suggests that aforementioned racial differences in A1C change patterns may 






Although 50% of this sample of veterans had optimal A1C levels below 7%, this 
still indicates that there is a large portion of veteran with diabetes that may have some 
difficulty achieving glycemic control. An important finding of this study is that A1C 
levels vary by race and by diagnostic group, with Black American veterans and veterans 
with sexual dysfunction having the most significant changes in A1C as they grew older. 
These results also indicated that the changes in A1C levels and for Black and White 
American veterans and veterans with sexual dysfunction are best represented by 
quadratic modeling vs. linear modeling. For some of this study’s analyses, the quadratic 
modeling provided more specific information regarding the trend of change in A1C 
levels, as it better captured changes in A1C levels that may naturally occur the longer a 
person has diabetes. These results also revealed that tracking changes in A1C levels as a 
person grows older can highlight important role of age on a person’s ability to manage 
their diabetes. These findings suggest that future studies examining factors impacting 
changes in glycemic control over time should explore possible curvilinear trajectories for 
changes in A1C levels, as well as model time as a representation of age to best 
understand glycemic control the longer a person has diabetes and as they grow older. 
Many studies have explored a number of factors potentially impacting an 
individual’s ability to achieve and maintain glycemic control, including depression and 
sexual dysfunction. The existing literature on the impact of depression or sexual 
dysfunction on glycemic control is mixed, with some studies reporting significant 
differences in glycemic control between individuals with and without depression or 




suggest that diagnoses of depression and/or sexual dysfunction may significantly impact 
the ability of veterans to achieve glycemic control, and are important factors to consider 
when assessing a patient’s ability to effectively manage their diabetes.   
It seems particularly important to acknowledge the potential biopsychosocial 
impact of sexual dysfunction as it relates to glycemic control. A sexual dysfunction 
diagnoses could simply be a reflection of poor glycemic control, such that individuals 
with poor glycemic control are at greater risk for developing diabetes-related health 
complications, such as sexual dysfunction. However, a sexual dysfunction diagnosis 
could also have significant psychosocial consequences related to being unable to perform 
sexually, including decreased sense of self-worth and relationship difficulties. Given 
research findings suggesting a reciprocal relationship between sexual dysfunction and 
depression, in that the presence of either one of these conditions may trigger or 
exacerbate the other (Kennedy & Razvi, 2009), a diagnosis of sexual dysfunction could 
be related to psychological distress, and perhaps depression. Negative moods associated 
with this distress can lead to a reduction in overall mind-body functioning manifesting 
behaviorally as poor adherence to diet, exercise, and medication regiments required to 
maintain healthy blood sugar levels and achieve glycemic control.  
Given the mixed findings in the literature regarding the impact of depression on 
glycemic control, this study’s findings highlight the possibility that this relationship could 
be mediated by difficulties with sexual dysfunction. Additional research exploring the 
impact of depression and sexual dysfunction on glycemic control is needed. Also, given 
this study’s findings of significant improvements in glycemic control as veterans with 




other than age of diabetes diagnosis, that may be contributing to reduced A1C levels as 
they age, such as differences in diabetes treatment (e.g., veterans with sexual dysfunction 
may receive more medical attention, be on higher doses of insulin, or pharmacological 
treatment of the sexual dysfunction improves motivation and ability to manage diabetes, 
etc.).  
To further increase understanding of the impact of depression on glycemic 
control, this study’s results suggest considering race as having an important influence on 
the relationship. Findings generally suggest that Black American veterans may struggle 
with higher A1C levels during their journey to achieve glycemic control when compared 
to White American veterans, but they appear to reach a turning point and start down the 
path of better controlling their diabetes at an earlier age compared to White American 
veterans. This implies that although White American veterans may have lower A1C 
levels to manage compared to Black American veterans, they are still at less than optimal 
A1C levels and may stay at these levels for longer periods of time before start down the 
path of better controlling their diabetes. This implies that treatment planning for White 
American veterans with diabetes may need to factor in the age, specifically the potential 
to develop health complications related to aging (e.g., sensory decline, reduced cognitive 
functioning, reduced physical functioning, etc.), and how these factors may further 
impact the veteran’s ability to achieve glycemic control. This study’s findings indicating 
racial differences in glycemic control among veterans with depression, suggest that 
depression may impact Black and White American veterans differently, given their 
different paths to achieving glycemic control. For example, depression may be more 




veterans with diabetes, causing their A1C levels to gradually increase as they age. 
Additional research is needed to explore the possible moderation effects of race on the 
relationship between depression severity and glycemic control. 
In general, this study’s findings highlight the overall importance of better 
understanding of the impact of emotional or psychological distress on a veteran’s ability 
to manage his diabetes. Increased attention and understanding of psychological issues can 
be achieved by health care providers working together with behavioral health specialists. 
Health care models that emphasize a multi-disciplinary approach to health care can be an 
effective method of helping veterans with diabetes manage their illness as well as manage 
co-morbid emotional or psychological issues. Another way to obtain a better sense of the 
impact of psychological and emotional distress on glycemic control among veterans is to 
assess specifically for diabetes-related stress as opposed to depression. Fisher and 
colleagues (2010) analyzed cross-sectional and longitudinal data for a relationship 
between major depressive disorder and diabetes distress. They found that emotional 
distress specifically tied to diabetes and its management has both cross-sectional and 
longitudinal relationships with A1C, whereas MDD had no impact on glycemic control 
(Fisher et al., 2010). The authors suggested the relationship between diabetes-specific 
distress and glycemic control is bidirectional, such that high levels of diabetes distress 
can influence self-management and medication adherence with subsequent effects of 
glycemic control; on the other hand, poor glycemic control can lead to distress which 
could subsequently influence diabetes management. The results of this study suggest that 
assessing for diabetes distress may be informative for treatment planning among veterans 





While this study has important strengths, there are a number of study limitations 
that can be improved upon by future studies. One such limitation is that this study was 
designed to test only quadratic trajectories for factors potentially impacting changes in 
glycemic control. A test for a quadratic trajectory only assesses for one inflection point (a 
peak or a valley), but the pattern of change in A1C level could have multiple peaks and 
valleys over an individual’s lifetime. More complex forms than quadratic (e.g., cubic) 
were not tested due to possible inflation in the number of terms given the complexity of 
this study’s proposed questions. Future studies could assess the possibility of more 
complex trajectories for change in glycemic control on more simplified models with 
fewer predicators. 
Despite the statistical significance for these analyses, it is important to note that 
mean differences in A1C levels did not appear to be clinically significant when compared 
to estimates of mean differences between members of racial and ethnic minority groups 
and White Americans found in the diabetes literature, namely 0.65% corresponding to a 
moderate effect size of 0.31 (Kirk et al., 2005). However, the design of the current study 
is unique compared to the designs of the studies reporting racial and ethnic differences in 
glycemic control, making it clinical significance of this study’s findings difficult to 
compare to existing standards in the literature. Specifically, most studies utilize cross-
sectional designs as opposed to longitudinal designs, limiting the ability of these study’s 
authors to make inferences about racial and ethnic differences in glycemic control over 
time. Also, to this author’s knowledge there are no existing longitudinal studies 




findings show that differences in A1C levels between Black and White American 
veterans disappear as they increase in age, highlighting the importance of age in the 
pattern of change in A1C levels. Furthermore, many of the studies comparing glycemic 
control between Black and White Americans had both groups reporting A1C levels in the 
uncontrolled range (> 8%), potentially contributing to a higher mean difference. Given 
these differences, the currently literature may not provide sufficient information on which 
to base clinical significance of this study’s findings. 
Due the demographic characteristics of the study’s sample, the study’s results 
may have limited generalizability. For one, prior to removing females and members of 
racial and ethnic groups other than non-Hispanic Black and non-Hispanic White for 
generalizability purposes, the original study sample did not appear to include non-White 
Hispanics. Given the documented prevalence of diabetes among this population as well 
as research indicating possible difficulties with sexual dysfunction among non-White 
Hispanics, this would have been an important population to include in this studies 
analyses, and their absence from the sample may have significantly impacted the results. 
It is possible than non-White Hispanics appeared to be excluded from the final study 
sample due to a coding error in the VA patient database that led to non-White Hispanics 
being categorized as non-Hispanic White, non-Hispanic Black, or Native American. 
Given the growing non-White Hispanic population in the U.S., future research examining 
racial and ethnic differences in glycemic control should be sure to included non-White 





Generalizability of results to the general population may also be limited due to 
using a veteran sample, specifically a veteran sample who receives their health care 
services from a VA medical center. Income requirements must be met in order for 
veterans to qualify for VA services, so the population receiving health care services at a 
VA medical center tends to be older males of low SES, and with more co-morbid health 
conditions. Veterans receiving services at a VA medical center may also have more co-
morbid mental health issues in addition to depression, including posttraumatic stress 
disorder, psychotic disorders, and substance abuse. While the unique qualities of this 
study’s population highlight the importance of conducting more research specifically 
addressing the needs of veterans who receive their care at the VA, it would also be 
important to replicate this study using a non-veteran sample or conduct comparison 
studies to capture potential population differences in factors that influence glycemic 
control.  
Another study limitation was the use of diagnoses to define depression. A 
diagnosis of depression is less meaningful than actual measurements of depression over 
time and does not reflect a level of severity. Furthermore, the use of depression diagnoses 
associated with billable clinical encounters may have inflated this study’s prevalence of 
depression, possibly misrepresenting the number of veterans with depression. Almost 
90% of veterans in this study’s sample had at least one billable encounter that included a 
depression diagnosis. Such a huge proportion hinders the study’s statistical power to 
detect significant differences in mean A1C levels between the diagnostic groups. Future 
VA studies should assess depression by using measures such as the Patient Health 




diagnoses (Beck, Steer, Ball, & Ranieri, 1996; Spitzer, Kroenke, & Williams, 1999). The 
use of such measures would allow for a better understanding of the effect of depression 
on A1C levels over time. 
While this study excluded veterans with schizophrenia and bipolar disorder, other 
common psychological disorders found in a veteran population were not screened or 
controlled for, namely posttraumatic stress disorder and substance abuse. It is possible 
that these disorders potentially increase A1C levels and negatively influence the efforts of 
veterans with diabetes in achieving glycemic control. I also did not screen for veterans 
who were receiving disability compensation from the VA based on their presumed 
exposure to Agent Orange or other herbicides, as this information was not available in the 
database. Previous literature has demonstrated a relationship between dioxin (the primary 
contaminant in Agent Orange and other herbicides) exposure and increased insulin 
resistance, the precursor to type 2 diabetes (Henriksen, Ketchum, Michalek, & Swaby, 
1997). Therefore, veterans exposed to dioxin may have a biological susceptibility to 
developing type 2 diabetes, which could have a negative impact on A1C levels. Future 
studies  should explore the effects of psychological disorders and biological susceptibility 
on glycemic control. 
Conclusion 
Given the ever-increasing prevalence of diabetes in the U.S. and the particularly 
high prevalence of diabetes among members of racial and ethnic minority groups and 
veteran populations, understanding the factors impacting diabetes-related health 
outcomes seems crucial to the effective treatment of diabetes in these populations. This 




related to chronic illness, and the need to include assessment and treatment of mental 
health issues as an integral part of diabetes management strategies for veterans, 
particularly for veterans whose health outcomes are more significantly impacted by 
psychological distress. This study also highlighted the potential importance of a 
biopsychosocial approach to understanding individual health and the potential utility of a 
multidisciplinary approach to health care. Continuing to expand literature in this area 
could provide increased understanding of the relationship between physical and mental 
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